On the other hand, PLAUR and MRC2 are involved in the activation of plasminogen and, although the benefit of targeting these proteins in fibrosis remains to be fully demonstrated, encouraging results have been reported for cancer settings (73–76). Here, MRC2 is linked to cancer.